A previous study reported that the upregulation of piR-Hep in hepatocellular carcinoma could promote hepatocellular cell proliferation via binding with PIWI2/HILI to affect PI3K/AKT signaling [17]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.